FindTrial
Sign In

Clinical Study on Epstein-Barr Virus-Associated Poxvirus-Like Lymphoproliferative Disorder

Clinical Study on Epstein-Barr Virus-Associated Poxvirus-Like Lymphoproliferative Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112983
Enrollment
Unknown
Registered
2025-11-21
Start date
2021-09-12
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydroa Vacciniforme-Like Lymphoproliferative Disorder

Interventions

Observational group:None

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years

Inclusion criteria

Inclusion criteria: Patients aged 3-18 years who meet the diagnostic criteria for poxvirus-like lymphoproliferative disorder, informed of the purpose and content of this study, and voluntarily agree to follow-up.

Exclusion criteria

Exclusion criteria: Patients previously diagnosed with known immunodeficiency, autoimmune disease

Design outcomes

Primary

MeasureTime frame
Systematic profiling of lymphocyte subsets;Immunohistochemistry;Histopathology;Programmed cell death protein 1,PD-1;Programmed cell death 1 ligand 1,PD-L1;—

Countries

China

Contacts

Public ContactLuo Xiaoyan

Children's Hospital of Chongqing Medical University

xyluo@hospital.cqmu.edu.cn+86 130 1238 1671

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026